{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:57:37Z","timestamp":1792587457744,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejogrb.2025.114003","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T19:02:31Z","timestamp":1745607751000},"page":"114003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Safety of ifosfamide during pregnancy: A comprehensive analysis"],"prefix":"10.1016","volume":"311","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5274-1294","authenticated-orcid":false,"given":"Charlotte","family":"Devant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Pietri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Auffret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lagarce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Barrois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Treluyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Tsatsaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9626-3571","authenticated-orcid":false,"given":"Laurent","family":"Chouchana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2025.114003_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0305-7372(85)90011-8","article-title":"Ifosfamide\u2013pharmacology, safety and therapeutic potential","volume":"12","author":"Brade","year":"1985","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejogrb.2025.114003_b0010","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1158\/0008-5472.CAN-06-1043","article-title":"Ifosfamide-induced nephrotoxicity: mechanism and prevention","volume":"66","author":"Nissim","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejogrb.2025.114003_b0015","first-page":"1091","article-title":"Nephrotoxicity of ifosfamide\u2013moving towards understanding the molecular mechanisms","volume":"12","author":"Rossi","year":"1997","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"10.1016\/j.ejogrb.2025.114003_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111708","article-title":"Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management","volume":"139","author":"Rawat","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ejogrb.2025.114003_b0025","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/pbc.23252","article-title":"Soft tissue sarcoma across the age spectrum: a population-based study from the surveillance epidemiology and end results database","volume":"57","author":"Ferrari","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejogrb.2025.114003_b0030","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3390\/cancers13061238","article-title":"Cancer during pregnancy: a review of preclinical and clinical transplacental transfer of anticancer agents","volume":"13","author":"Benoit","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejogrb.2025.114003_b0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2002-0279","article-title":"Coexistence of pregnancy and malignancy","volume":"7","author":"Pavlidis","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.ejogrb.2025.114003_b0040","first-page":"10314","article-title":"Impact of chemotherapy during pregnancy on fetal growth","volume":"35","author":"Maggen","year":"2022","journal-title":"J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet"},{"issue":"658","key":"10.1016\/j.ejogrb.2025.114003_b0045","first-page":"e1","article-title":"Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls","volume":"212","author":"Cardonick","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.114003_b0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3816\/CLM.2001.n.023","article-title":"Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero","volume":"2","author":"Avil\u00e9s","year":"2001","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.ejogrb.2025.114003_b0055","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00280-011-1707-8","article-title":"Doxorubicin and ifosfamide for high-grade sarcoma during pregnancy","volume":"69","author":"Mir","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ejogrb.2025.114003_b0060","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-2125.2011.04037.x","article-title":"Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database: commentary","volume":"72","author":"Montastruc","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejogrb.2025.114003_b0065","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/jac\/dkad087","article-title":"Assessing the risk of adverse pregnancy outcomes and birth defects reporting in women exposed to ganciclovir or valganciclovir during pregnancy: a pharmacovigilance study","volume":"78","author":"Contejean","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejogrb.2025.114003_b0070","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoae072","article-title":"Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase)","volume":"2025","author":"Henry","year":"2025","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.ejogrb.2025.114003_b0075","doi-asserted-by":"crossref","unstructured":"Sandberg L, Raemaekers B, Taavola H, Wallberg M, Quirant L, Rudolph A, et al. An algorithm to identify case reports with pregnancy exposure to medicinal products in vigiBase. Drug Saf, vol. 46, Bali, Indonesia: 2023, p. 1173\u2013295. https:\/\/doi.org\/10.1007\/s40264-023-01350-z.","DOI":"10.1007\/s40264-023-01350-z"},{"key":"10.1016\/j.ejogrb.2025.114003_b0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.urology.2004.05.032","article-title":"Spinal cord compression and lung metastasis of Wilms\u2019 tumor in a pregnant adolescent","volume":"64","author":"Corapcioglu","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.ejogrb.2025.114003_b0085","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/028418698430106","article-title":"Soft tissue and bone sarcomas in association with pregnancy","volume":"37","author":"Merimsky","year":"1998","journal-title":"Acta Oncol Stockh Swed"},{"key":"10.1016\/j.ejogrb.2025.114003_b0090","article-title":"A case of retroperitoneal synovial sarcoma in pregnancy treated with antepartum doxorubicin plus ifosfamide chemotherapy","volume":"2021","author":"Sipe","year":"2021","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.ejogrb.2025.114003_b0095","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/pd.1970090913","article-title":"Anhydramnios and cessation of fetal growth in a pregnant mother with polychemotherapy during the second trimester","volume":"9","author":"Fernandez","year":"1989","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ejogrb.2025.114003_b0100","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1002\/cam4.4707","article-title":"Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and\/or ifosfamide during pregnancy","volume":"11","author":"Miller","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejogrb.2025.114003_b0105","unstructured":"FDA. Highlights of prescribing information \u2013 Ifex. 2012."},{"key":"10.1016\/j.ejogrb.2025.114003_b0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1200\/JCO.1993.11.1.173","article-title":"Ifosfamide, mesna, and nephrotoxicity in children","volume":"11","author":"Skinner","year":"1993","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejogrb.2025.114003_b0115","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.nephro.2018.02.008","article-title":"Ifosphamide nephrotoxicity","volume":"14","author":"Ensergueix","year":"2018","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.ejogrb.2025.114003_b0120","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/j.ajkd.2013.11.028","article-title":"Chronic ifosfamide toxicity: kidney pathology and pathophysiology","volume":"63","author":"Akilesh","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejogrb.2025.114003_b0125","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00467-004-1807-3","article-title":"Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity","volume":"20","author":"Aleksa","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ejogrb.2025.114003_b0130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11626-999-0080-y","article-title":"Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells","volume":"35","author":"Springate","year":"1999","journal-title":"Vitro Cell Dev Biol - Anim"},{"key":"10.1016\/j.ejogrb.2025.114003_b0135","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1681\/ASN.V1281615","article-title":"Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide","volume":"12","author":"Dubourg","year":"2001","journal-title":"J Am Soc Nephrol JASN"},{"key":"10.1016\/j.ejogrb.2025.114003_b0140","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1159\/000358680","article-title":"The nephrotoxic Ifosfamide-metabolite chloroacetaldehyde interferes with renal extracellular matrix homeostasis","volume":"33","author":"Benesic","year":"2014","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"10.1016\/j.ejogrb.2025.114003_b0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00006254-199106000-00002","article-title":"Oligohydramnios: a review","volume":"46","author":"Peipert","year":"1991","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ejogrb.2025.114003_b0150","first-page":"373","article-title":"Accuracy of the ultrasound estimate of the amniotic fluid volume (amniotic fluid index and single deepest pocket) to identify actual low, normal, and high amniotic fluid volumes as determined by quantile regression","volume":"39","author":"Hughes","year":"2020","journal-title":"J Ultrasound Med Off J Am Inst Ultrasound Med"},{"key":"10.1016\/j.ejogrb.2025.114003_b0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1097-0096(199706)25:5<249::AID-JCU5>3.0.CO;2-D","article-title":"The accuracy of ultrasound evaluation of amniotic fluid volume in singleton pregnancies: the effect of operator experience and ultrasound interpretative technique","volume":"25","author":"Magann","year":"1997","journal-title":"J Clin Ultrasound JCU"},{"key":"10.1016\/j.ejogrb.2025.114003_b0160","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1469-0705.1996.07020108.x","article-title":"Outcome of singleton pregnancies with severe oligohydramnios in the second and third trimesters","volume":"7","author":"Shipp","year":"1996","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.114003_b0165","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00467-017-3833-y","article-title":"Causes of renal oligohydramnios: impact on prenatal counseling and postnatal outcome","volume":"33","author":"Loos","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ejogrb.2025.114003_b0170","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.reprotox.2011.02.008","article-title":"Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers","volume":"31","author":"Diav-Citrin","year":"2011","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ejogrb.2025.114003_b0175","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/s12884-022-04986-4","article-title":"Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort","volume":"22","author":"Dathe","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ejogrb.2025.114003_b0180","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-012-2368-y","article-title":"Trastuzumab administration during pregnancy: a systematic review and meta-analysis","volume":"137","author":"Zagouri","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejogrb.2025.114003_b0185","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3181\/00379727-143-37450","article-title":"Teratogenicity and neonatal toxicity of ifosfamide in mice","volume":"143","author":"Bus","year":"1973","journal-title":"Proc Soc Exp Biol Med Soc Exp Biol Med N Y N"},{"key":"10.1016\/j.ejogrb.2025.114003_b0190","first-page":"773","article-title":"Doxorubicin in pregnancy: possible transplacental passage","volume":"67","author":"Karp","year":"1983","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ejogrb.2025.114003_b0195","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(79)92878-2","article-title":"Does doxorubicin cross the placenta?","volume":"2","author":"Roboz","year":"1979","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ejogrb.2025.114003_b0200","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00467-018-3976-5","article-title":"Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study","volume":"33","author":"McMahon","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ejogrb.2025.114003_b0205","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1200\/JCO.2008.17.5257","article-title":"Long-term evaluation of ifosfamide-related nephrotoxicity in children","volume":"27","author":"Oberlin","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2025.114003_b0210","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0022-3476(82)80338-7","article-title":"Detection of human teratogenic agents","volume":"101","author":"Shepard","year":"1982","journal-title":"J Pediatr"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525002787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525002787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:46:56Z","timestamp":1774928816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525002787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":42,"alternative-id":["S0301211525002787"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114003","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of ifosfamide during pregnancy: A comprehensive analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114003"}}